|Articles|November 2, 2002
- Pharmaceutical Technology-11-02-2002
- Volume 26
- Issue 11
Residual Solvent Analysis in Pharmaceuticals
Author(s)Anil M. Dwivedi, PhD
The author discusses the current pharmacopeial status of the acceptance limits and classifications of pharmaceutical residual solvents.
Advertisement
Articles in this issue
about 23 years ago
Contract Servicesabout 23 years ago
Major Changes Ahead for FDANewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA, Duke University Planning Epinephrine Access Workshop for December
2
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
3
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part I
4
How ten23 health is Advancing Patient-Centric Drug Delivery
5
